{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:02:17Z","timestamp":1783382537156,"version":"3.54.6"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s00345-019-02924-2","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T10:44:20Z","timestamp":1567075460000},"page":"1473-1479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Necessity of differentiating small (&lt;\u200910\u00a0mm) and large (\u2265\u200910\u00a0mm) PI-RADS 4"],"prefix":"10.1007","volume":"38","author":[{"given":"Sung Yoon","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4114-8859","authenticated-orcid":false,"given":"Byung Kwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,29]]},"reference":[{"key":"2924_CR1","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","volume":"69","author":"JC Weinreb","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, Margolis D, Schnall MD, Shtern F, Tempany CM, Thoeny HC, Verma S (2016) PI-RADS prostate imaging\u2014reporting and data system: 2015, version 2. Eur Urol 69:16\u201340","journal-title":"Eur Urol"},{"key":"2924_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.eururo.2015.08.038","volume":"69","author":"JO Barentsz","year":"2016","unstructured":"Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F, Padhani AR, Margolis D, Macura KJ, Haider MA, Cornud F, Choyke PL (2016) Synopsis of the PI-RADS v2 guidelines for multiparametric prostate magnetic resonance imaging and recommendations for use. Eur Urol 69:41\u201349","journal-title":"Eur Urol"},{"key":"2924_CR3","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1148\/rg.2016150234","volume":"36","author":"AS Purysko","year":"2016","unstructured":"Purysko AS, Rosenkrantz AB, Barentsz JO, Weinreb JC, Macura KJ (2016) PI-RADS version 2: a pictorial update. Radiographics 36:1354\u20131372","journal-title":"Radiographics"},{"key":"2924_CR4","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1148\/radiol.2017161316","volume":"285","author":"MD Greer","year":"2017","unstructured":"Greer MD, Shih JH, Lay N, Barrett T, Kayat Bittencourt L, Borofsky S, Kabakus IM, Law YM, Marko J, Shebel H, Mertan FV, Merino MJ, Wood BJ, Pinto PA, Summers RM, Choyke PL, Turkbey B (2017) Validation of the dominant sequence paradigm and role of dynamic contrast-enhanced imaging in PI-RADS version 2. Radiology 285:859\u2013869","journal-title":"Radiology"},{"key":"2924_CR5","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.juro.2018.05.003","volume":"200","author":"SL Hofbauer","year":"2018","unstructured":"Hofbauer SL, Maxeiner A, Kittner B, Heckmann R, Reimann M, Wiemer L, Asbach P, Haas M, Penzkofer T, Stephan C, Friedersdorff F, Fuller F, Miller K, Cash H (2018) Validation of prostate imaging reporting and data system version 2 for the detection of prostate cancer. J Urol 200:767\u2013773","journal-title":"J Urol"},{"key":"2924_CR6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.juro.2017.03.131","volume":"198","author":"S Mehralivand","year":"2017","unstructured":"Mehralivand S, Bednarova S, Shih JH, Mertan FV, Gaur S, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B (2017) Prospective evaluation of PI-RADS version 2 using the international society of urological pathology prostate cancer grade group system. J Urol 198:583\u2013590","journal-title":"J Urol"},{"key":"2924_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1148\/radiol.16151133","volume":"280","author":"SY Park","year":"2016","unstructured":"Park SY, Jung DC, Oh YT, Cho NH, Choi YD, Rha KH, Hong SJ, Han K (2016) Prostate cancer: PI-RADS version 2 helps preoperatively predict clinically significant cancers. Radiology 280:108\u2013116","journal-title":"Radiology"},{"key":"2924_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1148\/radiol.2016152827","volume":"283","author":"N Tan","year":"2017","unstructured":"Tan N, Lin WC, Khoshnoodi P, Asvadi NH, Yoshida J, Margolis DJ, Lu DS, Wu H, Sung KH, Lu DY, Huang J, Raman SS (2017) In-Bore 3-T MR-guided transrectal targeted prostate biopsy: prostate imaging reporting and data system version 2-based diagnostic performance for detection of prostate cancer. Radiology 283:130\u2013139","journal-title":"Radiology"},{"key":"2924_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1148\/radiol.2018170425","volume":"288","author":"JN Thai","year":"2018","unstructured":"Thai JN, Narayanan HA, George AK, Siddiqui MM, Shah P, Mertan FV, Merino MJ, Pinto PA, Choyke PL, Wood BJ, Turkbey B (2018) Validation of PI-RADS version 2 in transition zone lesions for the detection of prostate cancer. Radiology 288:485\u2013491","journal-title":"Radiology"},{"key":"2924_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1148\/radiol.2016161124","volume":"283","author":"AB Rosenkrantz","year":"2017","unstructured":"Rosenkrantz AB, Babb JS, Taneja SS, Ream JM (2017) Proposed adjustments to PI-RADS version 2 decision rules: impact on prostate cancer detection. Radiology 283:119\u2013129","journal-title":"Radiology"},{"key":"2924_CR11","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1001\/jama.1994.03510290050036","volume":"271","author":"JI Epstein","year":"1994","unstructured":"Epstein JI, Walsh PC, Carmichael M, Brendler CB (1994) Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271:368\u2013374","journal-title":"JAMA"},{"key":"2924_CR12","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0022-5347(17)32370-4","volume":"152","author":"JI Epstein","year":"1994","unstructured":"Epstein JI, Walsh PC, Brendler CB (1994) Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C). J Urol 152:1721\u20131729","journal-title":"J Urol"},{"key":"2924_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0022-5347(05)64671-X","volume":"168","author":"GS Jack","year":"2002","unstructured":"Jack GS, Cookson MS, Coffey CS, Vader V, Roberts RL, Chang SS, Smith JA Jr, Shappell SB (2002) Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors. J Urol 168:519\u2013524","journal-title":"J Urol"},{"key":"2924_CR14","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/cncr.20586","volume":"101","author":"PJ Bastian","year":"2004","unstructured":"Bastian PJ, Mangold LA, Epstein JI, Partin AW (2004) Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis. Cancer 101:2001\u20132005","journal-title":"Cancer"},{"key":"2924_CR15","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.eururo.2007.11.057","volume":"54","author":"C Jeldres","year":"2008","unstructured":"Jeldres C, Suardi N, Walz J, Hutterer GC, Ahyai S, Lattouf JB, Haese A, Graefen M, Erbersdobler A, Heinzer H, Huland H, Karakiewicz PI (2008) Validation of the contemporary epstein criteria for insignificant prostate cancer in European men. Eur Urol 54:1306\u20131313","journal-title":"Eur Urol"},{"key":"2924_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/j.1464-410X.2011.09979.x","volume":"108","author":"SF Oon","year":"2011","unstructured":"Oon SF, Watson RW, O\u2019Leary JJ, Fitzpatrick JM (2011) Epstein criteria for insignificant prostate cancer. BJU Int 108:518\u2013525","journal-title":"BJU Int"},{"key":"2924_CR17","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1111\/j.1464-410X.2009.09070.x","volume":"105","author":"SE Lee","year":"2010","unstructured":"Lee SE, Kim DS, Lee WK, Park HZ, Lee CJ, Doo SH, Jeong SJ, Yoon CY, Byun SS, Choe G, Hwang SI, Lee HJ, Hong SK (2010) Application of the Epstein criteria for prediction of clinically insignificant prostate cancer in Korean men. BJU Int 105:1526\u20131530","journal-title":"BJU Int"},{"key":"2924_CR18","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1111\/j.1464-410X.2010.09996.x","volume":"108","author":"SK Hong","year":"2011","unstructured":"Hong SK, Na W, Park JM, Byun SS, Oh JJ, Nam JS, Jeong CW, Choe G, Lee HJ, Hwang SI, Lee SE (2011) Prediction of pathological outcomes for a single microfocal (<\/=3\u00a0mm) Gleason 6 prostate cancer detected via contemporary multicore (>\/=12) biopsy in men with prostate-specific antigen\u2009<\/=10\u00a0ng\/mL. BJU Int 108:1101\u20131105","journal-title":"BJU Int"},{"key":"2924_CR19","first-page":"30","volume":"19","author":"K Chondros","year":"2015","unstructured":"Chondros K, Karpathakis N, Heretis I, Mavromanolakis E, Chondros N, Sofras F, Mamoulakis C (2015) Validation of revised Epstein\u2019s criteria for insignificant prostate cancer prediction in a Greek subpopulation. Hippokratia 19:30\u201333","journal-title":"Hippokratia"},{"key":"2924_CR20","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","volume":"22","author":"JO Barentsz","year":"2012","unstructured":"Barentsz JO, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, Rouviere O, Logager V, Futterer JJ (2012) ESUR prostate MR guidelines 2012. Eur Radiol 22:746\u2013757","journal-title":"Eur Radiol"},{"key":"2924_CR21","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s00330-013-2795-0","volume":"23","author":"F Bratan","year":"2013","unstructured":"Bratan F, Niaf E, Melodelima C, Chesnais AL, Souchon R, Mege-Lechevallier F, Colombel M, Rouviere O (2013) Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol 23:2019\u20132029","journal-title":"Eur Radiol"},{"key":"2924_CR22","unstructured":"Mottet N, van den Bergh RCN, Briers E, Bourke L, Cornford P, De Santis M, De Santis M, Gillessen S, Govorov A, Grummet J, Henry AM, Lam TB, Mason MD, van der Poel HG, van der Kwast TH, Rouvi\u00e8re O, Wiegel T, van denBroeck T, Cumberbatch M, Fossati N, Gross T, Lardas M, Liew M, Moris L, Schoots IG, Willemse PM (2019) EAU\u2014ESTRO\u2014ESUR\u2014SIOG guidelines on prostate cancer \nhttps:\/\/uroweb.org\/guidelines\/2019"},{"key":"2924_CR23","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.eururo.2007.05.011","volume":"52","author":"RC van den Bergh","year":"2007","unstructured":"van den Bergh RC, Roemeling S, Roobol MJ, Roobol W, Schroder FH, Bangma CH (2007) Prospective validation of active surveillance in prostate cancer: the PRIAS study. Eur Urol 52:1560\u20131563","journal-title":"Eur Urol"},{"key":"2924_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/bju.12639","volume":"115","author":"S Rais-Bahrami","year":"2015","unstructured":"Rais-Bahrami S, Siddiqui MM, Vourganti S, Turkbey B, Rastinehad AR, Stamatakis L, Truong H, Walton-Diaz A, Hoang AN, Nix JW, Merino MJ, Wood BJ, Simon RM, Choyke PL, Pinto PA (2015) Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies. BJU Int 115:381\u2013388","journal-title":"BJU Int"},{"key":"2924_CR25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/pcan.2015.29","volume":"18","author":"JP Radtke","year":"2015","unstructured":"Radtke JP, Boxler S, Kuru TH, Wolf MB, Alt CD, Popeneciu IV, Steinemann S, Huettenbrink C, Bergstraesser-Gasch C, Klein T, Kesch C, Roethke M, Becker N, Roth W, Schlemmer HP, Hohenfellner M, Hadaschik BA (2015) Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance. Prostate Cancer Prostatic Dis 18:288\u2013296","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2924_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.urology.2015.09.035","volume":"88","author":"M Fascelli","year":"2016","unstructured":"Fascelli M, Rais-Bahrami S, Sankineni S, Brown AM, George AK, Ho R, Frye T, Kilchevsky A, Chelluri R, Abboud S, Siddiqui MM, Merino MJ, Wood BJ, Choyke PL, Pinto PA, Turkbey B (2016) Combined biparametric prostate magnetic resonance imaging and prostate-specific antigen in the detection of prostate cancer: a validation study in a biopsy-naive patient population. Urology 88:125\u2013134","journal-title":"Urology"},{"key":"2924_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1148\/radiol.2017170129","volume":"285","author":"CK Kuhl","year":"2017","unstructured":"Kuhl CK, Bruhn R, Kramer N, Nebelung S, Heidenreich A, Schrading S (2017) Abbreviated biparametric prostate MR imaging in men with elevated prostate-specific antigen. Radiology 285:493\u2013505","journal-title":"Radiology"},{"key":"2924_CR28","first-page":"W1","volume":"212","author":"Z Kang","year":"2018","unstructured":"Kang Z, Min X, Weinreb J, Li Q, Feng Z, Wang L (2018) Abbreviated biparametric versus standard multiparametric MRI for diagnosis of prostate cancer: a systematic review and meta-analysis. AJR Am J Roentgenol 212:W1\u2013W9","journal-title":"AJR Am J Roentgenol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02924-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-019-02924-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-019-02924-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T23:30:33Z","timestamp":1598571033000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-019-02924-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,29]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["2924"],"URL":"https:\/\/doi.org\/10.1007\/s00345-019-02924-2","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,29]]},"assertion":[{"value":"19 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors have conflict of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was retrospectively performed on human participants but not animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"This retrospective study was approved by our IRB and the approval number is 2018-12-069-001. Informed consent was waived.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}